NCRNA Combined Therapy as Future Treatment Option for Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|42|6565-6574

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.42, 2014-12, pp. : 6565-6574

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antibody therapy as a future treatment option for Ebola virus infection

By Matsuno Keita   Takada Ayato  

Future Virology, Vol. 2, Iss. 6, 2007-11 ,pp. : 607-614

Future Medicine

Access to resources Recommend Favorite

Potential Synergies for Combined Targeted Therapy in the Treatment of Neuroendocrine Cancer

By Salazar Ramon  

Drugs, Vol. 71, Iss. 7, 2011-05 ,pp. : 841-852

Adis International

Access to resources Recommend Favorite

Curcumin in Combined Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 20, Iss. 42, 2014-12 ,pp. : 6682-6696

Bentham Science Publishers

Access to resources Recommend Favorite

Combined Treatment with PPAR-γ Agonists in Pancreatic Cancer: A Glimmer of Hope for Cancer Therapy?

By  

Current Cancer Drug Targets, Vol. 13, Iss. 4, 2013-01 ,pp. : 460-471

Bentham Science Publishers

Access to resources Recommend Favorite

Combined Modality Therapy of Esophageal Cancer

By Juergens Rosalyn A.   Forastiere Arlene  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 9, 2008-10 ,pp. : 851-861

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite